High-Throughput Methods for Variant Functional Assessment in Cardiac Disease
Circulation: Genomic and Precision Medicine · 2026
DOI: 10.1161/circgen.125.005239 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Circulation: Genomic and Precision Medicine, 2026. Verfasst von Richard E Dolder und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetic Medicine and Clinical Pharmacology, Department of Medicine, Vanderbilt Center for Arrhythmia Research and Therapeutics, Vanderbil…. Hauptthemen laut MEDLINE: Heart Diseases, Genetic Variation, High-Throughput Nucleotide Sequencing, High-Throughput Screening Assays. Die Arbeit nennt 141 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, BLRD VA, NHLBI NIH HHS.
Abstract (Originalsprache)
In vitro functional modeling of genetic variants has revolutionized our understanding of which variants can cause cardiac disorders, providing insights into their molecular underpinnings. This review provides an overview of high-throughput methods used for the functional assessment of variants implicated in inherited cardiac diseases. Advances in gene-editing technology now enable the efficient generation of cells expressing individual genetic variants or libraries of variants for robust functional studies. We discuss innovative assays that can evaluate dozens or hundreds of variants sequentially. For example, the electrophysiological properties of numerous cardiac ion channel variants in genes linked to inherited arrhythmias can be characterized using automated patch clamping. The mechanical properties of cardiomyocytes expressing candidate cardiomyopathy variants can be assessed using techniques such as atomic force microscopy, traction force microscopy, and impedance-based methods. Multiplexed assays of variant effect are an emerging family of techniques that use gene-specific or general assays, combined with next-generation sequencing, to characterize hundreds or thousands of pooled genetic variants. We examine the key advantages and limitations of each method and outline future goals for the field. Innovative in vitro studies of cardiac genetic variants will enhance our understanding of variant-disease relationships and improve diagnosis, screening, and treatment options for these disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Genetic Medicine and Clinical Pharmacology, Department of Medicine, Vanderbilt Center for Arrhythmia Research and Therapeutics, Vanderbilt University Medical Center, Nashville, TN (R.E.D., A.M.G.).
- Department of Medicine/Cardiology, Center for Cardiovascular Biology, Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, University of Washington, Seattle (C.E.F., A.M.L., K.…
- Cardiology Section/Hospital Specialty Medicine Service Line, VA Puget Sound Health Care System, Seattle, WA (K.-C.Y.).
ORCID-Profile: Richard E Dolder, Clayton E Friedman, Alexander M Loiben, Kai-Chun Yang, Andrew M Glazer
Förderung
- NIGMS NIH HHS
- BLRD VA
- NHLBI NIH HHS
- NHGRI NIH HHS
- American Heart Association-American Stroke Association
Zitieren
APA
Dolder, R. E., Friedman, C. E., Loiben, A. M., Yang, K. C., & Glazer, A. M. (2026). High-Throughput Methods for Variant Functional Assessment in Cardiac Disease. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.125.005239
Vancouver
Dolder RE, Friedman CE, Loiben AM, Yang KC, Glazer AM. High-Throughput Methods for Variant Functional Assessment in Cardiac Disease. Circulation: Genomic and Precision Medicine. 2026. doi:10.1161/circgen.125.005239
BibTeX
@article{Dolder2026,
author = {Dolder, Richard E and Friedman, Clayton E and Loiben, Alexander M and Yang, Kai-Chun and Glazer, Andrew M},
title = {High-Throughput Methods for Variant Functional Assessment in Cardiac Disease},
journal = {Circulation: Genomic and Precision Medicine},
year = {2026},
doi = {10.1161/circgen.125.005239}
}
EUVIMED